A Randomized Experiment of Malaria Diagnostic Testing and Conditional Treatment Subsidies to Increase the Proportion of Malaria Patients Receiving an ACT
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 20
- 试验地点
- 1
- 主要终点
- ACT uptake among patients testing positive for malaria during the exit interview
研究概览
简要总结
The goal of this study observational study is to test the effect of conditional subsidies for Rapid Diagnostic Tests (RDT) and Artemisinin Combination Therapies (ACT) on improving the management of malaria fevers that seek care in the retail sector. The main question it aims to answer is:
• Would a conditional subsidy scheme increase the proportion of clients with malaria receiving an ACT? Researchers will compare the proportion of patients with malaria receiving an ACT in the intervention arms to the control arm. Retail providers in the intervention arm have access to free RDTs and subsidized ACTs distributed by the research team and are asked to use a recommended retail price for the RDT and ACT. In addition, the providers in the intervention arm are trained in the use of RDTs and a mobile app that will prompt them to take and upload a picture of the RDT result. Retail providers in the control arm are trained in the use of RDTs but do not receive free RDTs or subsidized ACTs.
详细描述
The ultimate goal of the conditional subsidy scheme is to increase the proportion of patients with malaria that receives an artemisinin combination therapy (ACT) at the point of sale.
The objective of this study is to test the effect of providing low-cost malaria rapid diagnostic tests (RDT) and Artemisinin Combination Therapies (ACTs) to patients on improving the management of malaria fevers that receive care in private medicine retailers (PMR). During the study, malaria RDTs are provided free of charge to the private provider to conduct malaria-RDT testing at a low cost (at a set recommended retail price) for patients with a malaria-like illness. Subsidized ACTs are provided to the provider, conditional on the provider conducting the malaria RDT and selling the ACT at a low cost to patients testing positive for malaria. Outcomes will be measured by exit interviews on random days each month at participating PMRs.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
盲法说明
Primary outcome data is collected through Exit Interviewers. Exit interviews are conducted on randomly selected days each month and data collectors will be randomly assigned to participating private retailer.
入排标准
- 年龄范围
- 1 Year 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Participants who tested in the Private Medicine Retailer and/or purchased antimalarial (s) for themselves.
- •Individuals with malaria-like illness must be present at recruitment.
- •Older than one year of age.
排除标准
- •Any individual with signs of severe illness requiring immediate referral.
- •Individuals who have taken an antimalarial in the last seven days, including for the current illness.
- •Patients <18 years without a parent or legal guardian present.
- •Adults who are unable to consent for themselves
结局指标
主要结局
ACT uptake among patients testing positive for malaria during the exit interview
时间窗: From enrollment exiting the PMR until the rapid test is conducted and the exit interview is concluded (approx 30 min)
The proportion of patients with malaria that purchased an ACT during their visit to the PMR. For this outcome, a patient with malaria is anyone who has a malaria RDT performed and tests positive at the exit interview.
次要结局
- Case management of patients visiting the PMR suspected of having malaria(From enrollment exiting the PMR until the rapid test is conducted and the exit interview is concluded (approximately 30 min)])
- Out of pocket expenses incurred by patients suspected of having malaria(From enrollment exiting the PMR until the rapid test is conducted and the exit interview is concluded (approximately 30 min)])
- Proportion of untested clients who purchase ACTs(From enrollment exiting the PMR until the rapid test is conducted and the exit interview is concluded (approx 30 min))